玻璃体腔注射贝伐珠单抗或激光光凝治疗早产儿视网膜病变后屈光不正的纵向变化
本回顾性临床队列研究纳入2011至2020年接受玻璃体腔注射贝伐珠单抗(IVB)或激光治疗的早产儿视网膜病变(ROP)患儿,比较两组纵向睫状肌麻痹验光数据,中位随访3.2年、共789次验光。线性混合效应模型显示,激光治疗眼近视进展显著更快(P < .001),每100个激光光斑使近视进展增加约0.16屈光度;IVB本身未影响近视进展,但大幅减少了后续所需激光量。
要点
- 激光治疗眼的近视进展显著快于IVB治疗眼(P < .001),且不受是否联合IVB影响。
- 每100个激光光斑使近视进展增加约0.16屈光度。
- ROP分期与分区均显著影响近视进展,病变越重进展越快。
核心结论
- 激光治疗严重ROP会增加重度近视的倾向;在本样本中,IVB未影响近视进展,但大幅减少了治疗ROP所需后续激光量。
- 校正ROP分期与分区差异后,激光的效应仍然存在。
研究设计与样本
- 回顾性临床队列研究,纳入2011至2020年接受IVB治疗的ROP早产儿,并与同期接受激光治疗的ROP婴儿比较纵向睫状肌麻痹验光数据。
- 部分接受IVB治疗的婴儿还接受了额外激光治疗;共纳入中位3.2年随访的789次累积验光的睫状肌麻痹验光数据。
- 采用带对数衰减函数的线性混合效应模型评估治疗后屈光随年龄的变化。
主要发现
- 总体模型估计屈光从轻度远视向相对更近视状态变化,趋势显著(P < .001)。
- 无论是否接受IVB治疗,激光治疗眼的进展均显著更快(P < .001)。
- 激光光斑数量使近视进展增加约0.16屈光度/100个激光光斑。
- ROP分期和分区均对近视进展有显著影响,病变越严重近视进展越快。
- 包括个体差异及左右眼嵌套方差的随机效应,解释了年龄和治疗未解释的剩余方差的86.4%。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To compare progression of myopia and refractive error in former premature infants with retinopathy of prematurity (ROP) treated using intravitreal bevacizumab (IVB) or laser. DESIGN: Retrospective clinical cohort study. METHODS: We identified premature infants with ROP treated using IVB from 2011 to 2020 and compared their longitudinal cycloplegic refraction data to that of infants with ROP treated using laser during the same timeframe. A subset of infants treated using IVB also underwent additional treatment using laser. We included cycloplegic refractions from 789 cumulative visits over a median 3.2 years. We used a linear mixed-effects model with a log decay function to evaluate how refraction changed with age after treatment. RESULTS: In aggregate, the model estimated a significant (P < .001) trend in refraction-from slight hyperopia to relatively more myopic states. However, progression in laser-treated eyes was significantly (P < .001) more rapid, regardless of treatment with IVB. The number of laser spots resulted in increased myopic progression by approximately 0.16 diopters per 100 laser spots. Both ROP stage and zone had a significant effect on myopic progression, with more severe disease resulting in faster myopic progression. Random effects, including individual subject variation with nested variance for left and right eye, accounted for 86.4% of the remaining variance not explained by age and treatment. CONCLUSIONS: Laser treatment for severe ROP increases the trend to severe myopia. In our sample, IVB did not affect myopic progression but did substantially reduce the amount of consequent laser required to treat ROP. The effect of laser persists after accounting for differences in ROP stage and zone.
引用
- Wiecek E, Akula JD, Vanderveen DK, et al. Longitudinal Change of Refractive Error in Retinopathy of Prematurity Treated With Intravitreal Bevacizumab or Laser Photocoagulation. Am J Ophthalmol. 2022. PMID: 35367438. doi:10.1016/j.ajo.2022.03.020
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。